Kyndryl Holdings to Announce FQ3 Earnings on February 9
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Feb 06 2026
0mins
Should l Buy KD?
Source: seekingalpha
Kyndryl Holdings (KD) shares rose 5.85% as the stock crossed above its 5-day SMA, reflecting positive market conditions.
The upcoming FQ3 earnings announcement on February 9 is a confirmed catalyst, with a consensus EPS estimate of $0.60 and revenue at $3.89 billion. Historical performance shows KD has beaten EPS estimates 75% of the time, which may bolster investor confidence. Additionally, Guggenheim's initiation of a 'Buy' rating indicates rising market interest in Kyndryl's growth potential, despite recent downward revisions in estimates.
This earnings report could significantly impact Kyndryl's stock price, especially if the company meets or exceeds expectations, attracting further investor interest.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy KD?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on KD
Wall Street analysts forecast KD stock price to rise
4 Analyst Rating
3 Buy
1 Hold
0 Sell
Strong Buy
Current: 12.700
Low
28.00
Averages
33.25
High
40.00
Current: 12.700
Low
28.00
Averages
33.25
High
40.00
About KD
Kyndryl Holdings, Inc. is a provider of mission-critical enterprise technology services offering advisory, implementation and managed service capabilities to customers in more than 60 countries. The Company designs, builds, manages and modernizes complex information systems around the world. Its segments include United States, Japan, Principal Markets and Strategic Markets. It offers services across domains, such as cloud services, core enterprise and zCloud services, applications, data and artificial intelligence (AI) services, digital workplace services, security and resiliency services and network and edge services. Its advisory and implementation services are branded as Kyndryl Consult. It provides end-to-end enterprise data services, including data transformation, data architecture and management, data governance and compliance and data migration. It provides comprehensive enterprise cybersecurity services for chief information security officers (CISOs) and chief risk officers.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Kyndryl's Financial Reporting Failures Trigger Class Action Lawsuit
- Financial Control Failures: Kyndryl's amended reports filed on February 17, 2026, revealed ineffective internal controls over financial reporting as of March, June, and September 2025, leading to a dramatic 55% drop in share price on February 9, 2026, severely undermining investor confidence.
- Executive Departures Impact: The sudden departure of the CFO and General Counsel on February 5, 2026, has heightened concerns about Kyndryl's management stability, resulting in a loss of over $2.4 billion in market capitalization, which adversely affects the company's financing capabilities and market reputation.
- SEC Investigation Intensifies Pressure: Kyndryl has received document requests from the SEC regarding cash management practices under review by the Audit Committee, which not only compromises the company's transparency but also poses potential legal repercussions, increasing investor risk.
- Class Action Lawsuit Progress: A securities class action lawsuit is underway against Kyndryl, representing investors who purchased securities between August 7, 2024, and February 9, 2026, potentially leading to substantial financial liabilities for the company, further impacting its financial stability and market trust.
See More
Faruqi & Faruqi Encourages Kyndryl Investors to Reach Out
- Legal Investigation: Faruq & Faruqi LLP is investigating potential claims against Kyndryl Holdings, Inc. related to securities purchased between August 7, 2024, and February 9, 2026, which may impact investor rights.
- Investor Contact Information: Securities Litigation Partner Josh Wilson encourages affected investors to contact him directly at 877-247-4292 or 212-983-9330 (Ext. 1310) to discuss their legal rights and options.
- Class Action Deadline: The firm reminds investors that the deadline to seek the role of lead plaintiff in a federal securities class action against Kyndryl is April 13, 2026, highlighting the importance of timely action.
- Investor Rights Protection: This investigation aims to protect investor rights and ensure they can seek compensation within the legal framework, reflecting uncertainties regarding Kyndryl's future performance and its potential impact on shareholders.
See More
Kyndryl Offers Canadian Businesses a Quick and Secure Solution for Migrating and Modernizing Essential Legacy Systems on Microsoft Azure
Canadian Enterprises: Kyndryl is providing Canadian enterprises with a fast and secure path to modernize their mission-critical legacy systems.
Microsoft Azure: The modernization efforts are being facilitated through the use of Microsoft Azure, enhancing efficiency and performance for businesses.
See More
Kyndryl Faces Class Action Lawsuit, Shares Plunge 55%
- Lawsuit Notification: Kahn Swick & Foti LLC has informed Kyndryl investors of a class action lawsuit due to alleged securities fraud affecting investors from August 7, 2024, to February 9, 2026, seeking to recover losses.
- Financial Reporting Delay: On February 9, 2026, Kyndryl disclosed its inability to timely file its Form 10-Q for the quarter ended December 31, 2025, anticipating material weaknesses in internal controls, which raises concerns about financial transparency.
- Executive Departures Impact: The departure of Kyndryl's CFO and General Counsel has exacerbated investor worries regarding corporate governance and financial health, leading to a decline in market confidence.
- Stock Price Plunge: Following the news of the lawsuit and financial issues, Kyndryl's stock price plummeted by 55%, dropping $12.90 per share to close at $10.59, reflecting a pessimistic outlook among investors regarding the company's future prospects.
See More
Multiple Companies Facing Class Action Lawsuits
- Oracle Lawsuit: Oracle Corporation is facing a class action lawsuit for the period from June 12 to December 16, 2025, due to its AI infrastructure strategy leading to significant capital expenditure increases, which could severely impact its debt and credit rating, with investor losses expected to exceed $50,000.
- Paysafe Risks: Paysafe Limited is being sued for the period from March 4 to November 12, 2025, for failing to disclose significant exposure to a single high-risk client in its e-commerce business, which is likely to negatively impact its revenue growth and may prevent it from meeting its financial guidance for fiscal year 2025.
- Inovio Pharmaceuticals Issues: Inovio Pharmaceuticals, Inc. is facing a class action lawsuit for the period from October 10, 2023, to December 26, 2025, due to deficiencies in manufacturing its CELLECTRA device, which is expected to hinder its ability to submit the INO-3107 BLA to the FDA by the second half of 2024, affecting its regulatory and commercial prospects.
- Kyndryl Financial Misstatements: Kyndryl Holdings, Inc. is being sued for the period from August 7, 2024, to February 9, 2026, due to materially misstated financial statements, which are expected to prevent timely filing of its Quarterly Report for the quarter ended December 31, 2025, raising concerns about its business outlook.
See More
Kyndryl Faces Class Action Lawsuit Impacting Stock Price
- Class Action Filed: Pomerantz LLP has initiated a class action lawsuit against Kyndryl, alleging securities fraud by the company and certain executives, with investors needing to apply as lead plaintiffs by April 13, 2026, indicating significant legal risks for the firm.
- Delayed Financial Reporting: On February 9, 2026, Kyndryl notified the SEC via Form 12b-5 that it could not file its 10-Q report for Q4 2025 on time, revealing an ongoing investigation into its financial reporting, which could undermine investor confidence.
- Frequent Executive Changes: On the same day, Kyndryl announced the immediate departures of CFO David Wyshner and General Counsel Edward Sebold, along with a role change for Senior VP Vineet Khurana, suggesting potential instability in the company's strategic direction due to high turnover.
- Stock Price Plummets: Following these announcements, Kyndryl's stock price fell by $12.90, or 55%, closing at $10.59 per share, reflecting extreme pessimism in the market regarding the company's future prospects, which may adversely affect its financing and operational capabilities.
See More
Kyndryl's Financial Reporting Failures Trigger Class Action Lawsuit
- Financial Control Failures: Kyndryl's amended reports filed on February 17, 2026, revealed ineffective internal controls over financial reporting as of March, June, and September 2025, leading to a dramatic 55% drop in share price on February 9, 2026, severely undermining investor confidence.
- Executive Departures Impact: The sudden departure of the CFO and General Counsel on February 5, 2026, has heightened concerns about Kyndryl's management stability, resulting in a loss of over $2.4 billion in market capitalization, which adversely affects the company's financing capabilities and market reputation.
- SEC Investigation Intensifies Pressure: Kyndryl has received document requests from the SEC regarding cash management practices under review by the Audit Committee, which not only compromises the company's transparency but also poses potential legal repercussions, increasing investor risk.
- Class Action Lawsuit Progress: A securities class action lawsuit is underway against Kyndryl, representing investors who purchased securities between August 7, 2024, and February 9, 2026, potentially leading to substantial financial liabilities for the company, further impacting its financial stability and market trust.
See More
Faruqi & Faruqi Encourages Kyndryl Investors to Reach Out
- Legal Investigation: Faruq & Faruqi LLP is investigating potential claims against Kyndryl Holdings, Inc. related to securities purchased between August 7, 2024, and February 9, 2026, which may impact investor rights.
- Investor Contact Information: Securities Litigation Partner Josh Wilson encourages affected investors to contact him directly at 877-247-4292 or 212-983-9330 (Ext. 1310) to discuss their legal rights and options.
- Class Action Deadline: The firm reminds investors that the deadline to seek the role of lead plaintiff in a federal securities class action against Kyndryl is April 13, 2026, highlighting the importance of timely action.
- Investor Rights Protection: This investigation aims to protect investor rights and ensure they can seek compensation within the legal framework, reflecting uncertainties regarding Kyndryl's future performance and its potential impact on shareholders.
See More
Kyndryl Offers Canadian Businesses a Quick and Secure Solution for Migrating and Modernizing Essential Legacy Systems on Microsoft Azure
Canadian Enterprises: Kyndryl is providing Canadian enterprises with a fast and secure path to modernize their mission-critical legacy systems.
Microsoft Azure: The modernization efforts are being facilitated through the use of Microsoft Azure, enhancing efficiency and performance for businesses.
See More
Kyndryl Faces Class Action Lawsuit, Shares Plunge 55%
- Lawsuit Notification: Kahn Swick & Foti LLC has informed Kyndryl investors of a class action lawsuit due to alleged securities fraud affecting investors from August 7, 2024, to February 9, 2026, seeking to recover losses.
- Financial Reporting Delay: On February 9, 2026, Kyndryl disclosed its inability to timely file its Form 10-Q for the quarter ended December 31, 2025, anticipating material weaknesses in internal controls, which raises concerns about financial transparency.
- Executive Departures Impact: The departure of Kyndryl's CFO and General Counsel has exacerbated investor worries regarding corporate governance and financial health, leading to a decline in market confidence.
- Stock Price Plunge: Following the news of the lawsuit and financial issues, Kyndryl's stock price plummeted by 55%, dropping $12.90 per share to close at $10.59, reflecting a pessimistic outlook among investors regarding the company's future prospects.
See More
Multiple Companies Facing Class Action Lawsuits
- Oracle Lawsuit: Oracle Corporation is facing a class action lawsuit for the period from June 12 to December 16, 2025, due to its AI infrastructure strategy leading to significant capital expenditure increases, which could severely impact its debt and credit rating, with investor losses expected to exceed $50,000.
- Paysafe Risks: Paysafe Limited is being sued for the period from March 4 to November 12, 2025, for failing to disclose significant exposure to a single high-risk client in its e-commerce business, which is likely to negatively impact its revenue growth and may prevent it from meeting its financial guidance for fiscal year 2025.
- Inovio Pharmaceuticals Issues: Inovio Pharmaceuticals, Inc. is facing a class action lawsuit for the period from October 10, 2023, to December 26, 2025, due to deficiencies in manufacturing its CELLECTRA device, which is expected to hinder its ability to submit the INO-3107 BLA to the FDA by the second half of 2024, affecting its regulatory and commercial prospects.
- Kyndryl Financial Misstatements: Kyndryl Holdings, Inc. is being sued for the period from August 7, 2024, to February 9, 2026, due to materially misstated financial statements, which are expected to prevent timely filing of its Quarterly Report for the quarter ended December 31, 2025, raising concerns about its business outlook.
See More
Kyndryl Faces Class Action Lawsuit Impacting Stock Price
- Class Action Filed: Pomerantz LLP has initiated a class action lawsuit against Kyndryl, alleging securities fraud by the company and certain executives, with investors needing to apply as lead plaintiffs by April 13, 2026, indicating significant legal risks for the firm.
- Delayed Financial Reporting: On February 9, 2026, Kyndryl notified the SEC via Form 12b-5 that it could not file its 10-Q report for Q4 2025 on time, revealing an ongoing investigation into its financial reporting, which could undermine investor confidence.
- Frequent Executive Changes: On the same day, Kyndryl announced the immediate departures of CFO David Wyshner and General Counsel Edward Sebold, along with a role change for Senior VP Vineet Khurana, suggesting potential instability in the company's strategic direction due to high turnover.
- Stock Price Plummets: Following these announcements, Kyndryl's stock price fell by $12.90, or 55%, closing at $10.59 per share, reflecting extreme pessimism in the market regarding the company's future prospects, which may adversely affect its financing and operational capabilities.
See More
